Gateway Deals in China

Many Western companies hope to extract additional value from assets by entering the high-growth Chinese market, but small to mid-cap companies in particular do not have the ability to establish operations there. 3SBio Inc. believes it can bridge this gap by providing partnering opportunities in Asia for western companies, which simultaneously helps build its own pipeline.

EVP and COO David Chen noted that 3SBio has an established commercial presence in China and the greater Asian region. It has five marketed products in the areas of oncology, nephrology and hematology, with a focus on biologics...